Cargando…
Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
After the publication of an article discussing the methodological options to detect the diversion potential of prescription drugs, this letter presents the multidimensional functioning of the French Addictovigilance System. This system aims at monitoring all substances with abuse potential, relying...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6672683/ https://www.ncbi.nlm.nih.gov/pubmed/31194866 http://dx.doi.org/10.1093/ijnp/pyz033 |
_version_ | 1783440580662001664 |
---|---|
author | Jouanjus, Emilie Micallef, Joëlle Mallaret, Michel Lapeyre-Mestre, Maryse |
author_facet | Jouanjus, Emilie Micallef, Joëlle Mallaret, Michel Lapeyre-Mestre, Maryse |
author_sort | Jouanjus, Emilie |
collection | PubMed |
description | After the publication of an article discussing the methodological options to detect the diversion potential of prescription drugs, this letter presents the multidimensional functioning of the French Addictovigilance System. This system aims at monitoring all substances with abuse potential, relying on a network of experts specialized in clinical and fundamental pharmacology. For more than 25 years, we have created collaborations with partners at the interface with field data related to substance use and the potential related disorders. When relevant depending on the context, these data sources are explored and crossed to analyze the abuse potential of one given substance. This organizational approach is useful to detect early Addictovigilance warning signals and to take appropriate measures. Generalizing such a multidimensional approach outside France appears an appealing option to move towards more effective Addictovigilance systems at the international level. |
format | Online Article Text |
id | pubmed-6672683 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-66726832019-08-05 Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions Jouanjus, Emilie Micallef, Joëlle Mallaret, Michel Lapeyre-Mestre, Maryse Int J Neuropsychopharmacol Letter to Editor After the publication of an article discussing the methodological options to detect the diversion potential of prescription drugs, this letter presents the multidimensional functioning of the French Addictovigilance System. This system aims at monitoring all substances with abuse potential, relying on a network of experts specialized in clinical and fundamental pharmacology. For more than 25 years, we have created collaborations with partners at the interface with field data related to substance use and the potential related disorders. When relevant depending on the context, these data sources are explored and crossed to analyze the abuse potential of one given substance. This organizational approach is useful to detect early Addictovigilance warning signals and to take appropriate measures. Generalizing such a multidimensional approach outside France appears an appealing option to move towards more effective Addictovigilance systems at the international level. Oxford University Press 2019-06-13 /pmc/articles/PMC6672683/ /pubmed/31194866 http://dx.doi.org/10.1093/ijnp/pyz033 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Letter to Editor Jouanjus, Emilie Micallef, Joëlle Mallaret, Michel Lapeyre-Mestre, Maryse Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions |
title | Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions |
title_full | Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions |
title_fullStr | Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions |
title_full_unstemmed | Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions |
title_short | Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions |
title_sort | comment on: an insight into z-drug abuse and dependence: an examination of reports to the european medicines agency database of suspected adverse drug reactions |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6672683/ https://www.ncbi.nlm.nih.gov/pubmed/31194866 http://dx.doi.org/10.1093/ijnp/pyz033 |
work_keys_str_mv | AT jouanjusemilie commentonaninsightintozdrugabuseanddependenceanexaminationofreportstotheeuropeanmedicinesagencydatabaseofsuspectedadversedrugreactions AT micallefjoelle commentonaninsightintozdrugabuseanddependenceanexaminationofreportstotheeuropeanmedicinesagencydatabaseofsuspectedadversedrugreactions AT mallaretmichel commentonaninsightintozdrugabuseanddependenceanexaminationofreportstotheeuropeanmedicinesagencydatabaseofsuspectedadversedrugreactions AT lapeyremestremaryse commentonaninsightintozdrugabuseanddependenceanexaminationofreportstotheeuropeanmedicinesagencydatabaseofsuspectedadversedrugreactions |